show higher efficacy with the IL-23s than with IL-12/23, with similar safety results,” Regueiro said. “To that end, I see the IL-23s replacing ustekinumab.” Findings from the phase 3 GALAXI ...

Nobody has pitched more innings in baseball than Aaron Nola since 2017. It speaks to his talents and durability.

It will compete with other biologic therapies for Crohn's, including J&J's IL-12 and IL-23 inhibitor Stelara (ustekinumab), Takeda's Entyvio (vedolizumab) and Biogen's Tysabri (natalizumab ...

Johnson & Johnson's IL-23 inhibitor Tremfya has been approved by ... as well as Skyrizi, which approached $12 billion in sales last year and is viewed as J&J's fiercest rival in the market.

New York Mets (29-18, first in the NL East) vs. Boston Red Sox (23-25, second in the AL East) Boston; Monday, 6:45 p.m. EDT PITCHING PROBABLES: Mets: Kodai Senga (4-2, 1.02 ERA, 1.17 WHIP, 42 ...

Yankees vs. Mariners Game 1 streams live on fuboTV (free trial). It will air in-market on YES Network and ROOT Sports ...

Atlanta Braves (23-23, third in the NL East) vs. Boston Red Sox (23-24, second in the AL East) Boston; Sunday, 1:35 p.m. EDT PITCHING PROBABLES: Braves: Spencer Schwellenbach (2-3, 3.31 ERA, 1.07 ...

The New York Mets were thought to be in danger of a disappointing season when they lost Sean Manaea and Frankie Montas to ...

Houston Astros (23-22, third in the AL West) vs. Texas Rangers (25-22, second in the AL West) Arlington, Texas; Sunday, 1:05 p.m. EDT PITCHING PROBABLES: Astros: Framber Valdez (2-4, 3.54 ERA, 1.14 ...

PITCHING PROBABLES: Rays: Zack Littell (2-5, 4.40 ERA, 1.11 WHIP, 30 strikeouts); Blue Jays: Kevin Gausman (3-3, 3.97 ERA, 0.97 WHIP, 40 strikeouts) ...

COLUMN. A structural imbalance has set in between the two countries, which goes beyond Chinese mercantilism and the ...

Held that once a Secured Creditor relinquishes its security interest to the liquidation estate, it cannot seek priority among other secured creditors on the basis of the charge and is only entitled to ...